|
|
||||||||
Articles |
In the present study, we have investigated the role of the multidrug resistance (mdr) P-glycoprotein (Pgp) at the blood-brain barrier in hampering the access of the synthetic glucocorticoid, prednisolone. In vivo, a tracer dose of [(3)H]prednisolone poorly penetrated the brain of adrenalectomised wild-type mice, but the uptake was more than threefold enhanced in the absence of Pgp expression in mdr1a (-/-) mice. In vitro, in stably transfected LLC-PK1 monolayers the human MDR1 P-glycoprotein was able to transport prednisolone present at a micromolar concentration. A specific Pgp blocker, LY 335979, could block this polar transport of [(3)H]prednisolone. Human Pgp does not transport all steroids, as cortexolone was not transported at all and aldosterone was only weakly transported. The ability of Pgp to export the synthetic glucocorticoid, prednisolone, suggests that uptake of prednisolone in the human brain is impaired, leading to a discrepancy between central and peripheral actions. Furthermore, the ensuing imbalance in activation of the two types of brain corticosteroid receptors may have consequences for cognitive performance and mood.
This article has been cited by other articles:
![]() |
A. Viana, S. Rates, B. Naudin, F. Janin, J. Costentin, and J-C. do Rego Effects of acute or 3-day treatments of Hypericum caprifoliatum Cham. & Schltdt. (Guttiferae) extract or of two established antidepressants on basal and stress-induced increase in serum and brain corticosterone levels J Psychopharmacol, August 1, 2008; 22(6): 681 - 690. [Abstract] [PDF] |
||||
![]() |
B. D. Anderson, M. J. May, S. Jordan, L. Song, M. J. Roberts, and M. Leggas DEPENDENCE OF NELFINAVIR BRAIN UPTAKE ON DOSE AND TISSUE CONCENTRATIONS OF THE SELECTIVE P-GLYCOPROTEIN INHIBITOR ZOSUQUIDAR IN RATS Drug Metab. Dispos., April 1, 2006; 34(4): 653 - 659. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sahasranaman, M. Issar, and G. Hochhaus METABOLISM OF MOMETASONE FUROATE AND BIOLOGICAL ACTIVITY OF THE METABOLITES Drug Metab. Dispos., February 1, 2006; 34(2): 225 - 233. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Karssen, O. C. Meijer, A. Berry, R. Sanjuan Pinol, and E. R. de Kloet Low Doses of Dexamethasone Can Produce a Hypocorticosteroid State in the Brain Endocrinology, December 1, 2005; 146(12): 5587 - 5595. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pavek, G. Merino, E. Wagenaar, E. Bolscher, M. Novotna, J. W. Jonker, and A. H. Schinkel Human Breast Cancer Resistance Protein: Interactions with Steroid Drugs, Hormones, the Dietary Carcinogen 2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine, and Transport of Cimetidine J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 144 - 152. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Grauer and M. Uhr P-glycoprotein reduces the ability of amitriptyline metabolites to cross the blood brain barrier in mice after a 10-day administration of amitriptyline J Psychopharmacol, March 1, 2004; 18(1): 66 - 74. [Abstract] [PDF] |
||||
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |